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Abstract
A decrease in serum zinc can be caused by a real zinc deficiency but can also be caused 
by an apparent zinc deficiency, e.g. in inflammatory stress. The aim of this study was to 
evaluate the diagnostic power of serum alkaline phosphatase (AP) activity in the discrimi­
nation between pathophysiologic states of “real” and “apparent” zinc deficiency. A decrease 
in serum zinc was induced in growing and adult rats, by providing a diet low in zinc and 
by causing inflammatory stress. AP activity was determined using reagents low or enriched 
in zinc. Serum AP was decreased in zinc-deficient adult rats (P < 0.01). In zinc-deficient 
growing rats AP activity was not different from normal rats but AP activity decreased 
rapidly. In the same growing rats a significant difference was found in AP activities 
determined using buffers low and enriched in zinc (P <  0.001) between both groups of rats. 
After inducing inflammatory stress a decrease in AP activity (P <  0.01) and serum zinc 
(P <  0.001) was seen during the first few days. After the initial phase of inflammation AP 
activity normalized, serum zinc showed a rise which after correction for the decrease in 
serum albumin reached the level of the control rats. A difference in AP activity in buffers 
low and enriched in zinc was observed only during the first few days after induction of 
inflammatory stress (P <  0.001). Probably the method of measurement of the difference in
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enzyme activity, using buffers low and enriched in zinc, can be used as an indication for 
zinc deficiency in situations with changing AP enzyme concentrations. AP activity is 
decreased during the initial phase of inflammatory stress due to a decrease in serum zinc.
Keywords: Zinc; Inflammatory stress; Rats; Serum alkaline phosphatase activity; Zinc 
deficiency; Serum albumin
1. Introduction
Zinc deficiency is a serious disorder expressed by a variety of symptoms 
such as delayed wound healing, dysfunction of the immune system, 
anorexia, decreased protein synthesis, night blindness, skin diseases, hair 
loss and growth retardation [1].
Usually the serum zinc concentration is used to determine zinc status 
[2], but the serum zinc concentration is not only decreased in real zinc 
deficiency, but also in stress [3]. During stress serum zinc is redistributed 
from the serum into the liver. In addition, the serum albumin concentra­
tion will decrease and since about 75% of serum zinc is bound to albumin 
[4], a decrease of serum albumin will result in a decrease of serum zinc. 
Because the decrease of serum zinc during stressful events does not result 
in symptoms characteristic of real zinc deficiency, this situation is called 
apparent zinc deficiency. Thus, serum zinc is not the perfect parameter for 
zinc status. Several other methods are used to determine zinc status, e.g. 
determination of zinc concentrations in urine [5], in hair [6], and in blood 
cells [7], All of these methods have disadvantages.
Zinc is a component of more than 200 enzymes [8]. In case of zinc 
deficiency, zinc-containing metallo-enzymes often do not function optimal­
ly. Alkaline phosphatase (AP) is one of these zinc-dependent metal­
lo-enzymes. Serum AP activity may be used to determine zinc status [9], 
but AP activity is also influenced by other factors, for instance growth. 
The aim of this study was to investigate the influence of a physiologically 
induced decrease in the serum zinc concentration, as in dietary-induced 
zinc deficiency and inflammatory stress, on serum AP activity in growing 
and adult rats. The concentration of zinc in the reagents influences the 
determination of AP activity [10-12]. In general for complete expression 
of serum AP activity a reagent supplemented with zinc is used. We made 
the hypothesis that, in case of real zinc deficiency, the difference in AP 
activity using buffers low and enriched in zinc is greater than in normal 
situations.
2. Materials and methods
2.1. Animals
In all experiments male Wistar rats were used. The rats were housed 
separately in stainless steel metabolic cages. Before the adaptation period 
the rats were fed commercial chow. The diet on which the rats were raised 
contained variable amounts of zinc (< 2 , 12 or 92 mg/kg; IRI-OB [13]). 
In Experiments 1,2, and 3, a diet containing 12 mg/kg zinc was given from
2 weeks before the start of the experiments, to adapt the animals to the 
diet and the metabolic cages. The zinc concentration of 12 mg/kg is 
considered sufficient to maintain a normal zinc status [14]. All blood 
samples were taken under ether anaesthesia by heart puncture. The 
guidelines for the care and use of laboratory animals in The Netherlands 
were followed.
2.2. Design o f the experiments
Five experiments were performed to study the influence of physiologi­
cally induced variations in zinc concentration on the AP activity. In the 
first 2 experiments zinc deficiency was induced in adult and, respectively, 
growing rats. The AP activity was studied. In the first experiment also the 
65Zn retention was determined as a gold standard for zinc status. In the 
third experiment adult rats were made zinc deficient and the AP activity 
was determined in buffers low and enriched in zinc. Because in the first 
experiment the effect of zinc supplementation in zinc deficiency was 
investigated, the fourth experiment was designed to study the influence of 
zinc supplementation in rats on a diet with a normal or a high zinc 
content. In the fifth experiment inflammatory stress was induced.
2.2.1. Experiment 1: zinc deficiency in adult rats, A P  activity and the effects 
o f  zinc supplementation
After adaptation (see above) 16 male rats (300 g) were injected i.p. with 
74 kBq (2 p d )  65Zn (day 0). Eight rats received a diet with an adequate 
amount of zinc (IRI-OB; 12 mg/kg Zn), 8 others were fed a zinc-deficient 
diet ( < 2  mg/kg Zn). After 1 month all rats received a diet with an 
adequate amount of zinc (12 mg/kg). The control group received pair 
feeding throughout the experiment. Blood (3 ml) was taken under ether 
anaesthesia by heart puncture on days 0, 7, 14, 21, 28 and 36. The serum 
was analyzed for zinc and magnesium concentration, albumin and for AP 
activity, in a buffer enriched in zinc. The total body retention of i.p. 
administered 65Zn served as reference for the degree of zinc deficiency.
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Total body counting was performed after 4 h and on days 0, 1, 2, 5, 9, 14, 
21, 28 and 35. The total body retention at day 1 was taken as 100%.
2.2.2. Experiment 2: zinc deficiency in growing rats, AP activity using 
buffers low and enriched in zinc
This experiment was identical to Experiment 1, but it was performed in 
young rats with a body weight of 100 g at the start of the adaptation 
period. Blood samples were taken at days 0, 17, 24, 37, 51, 65 for serum 
zinc and albumin assay, and for AP activity determination with reagents 
low or enriched in zinc.
2.2.3. Experiment 3: zinc deficiency in adidt rats, AP activity using buffers
low and enriched in zinc 
The difference was that serum AP activity was determined with reagents 
low or enriched in zinc content. Blood was withdrawn on days 0, 3, 7, 14, 
21, and 28.
2.2.4. Experiment 4: zinc supplementation in normal rats, AP activity 
After an adaptation period of 2 weeks, 32 Wistar rats (250 g) were
divided into 2 groups. Sixteen rats received a diet with an adequate 
amount of zinc (IRI-OB; 12 mg/kg Zn). Sixteen others received a diet 
enriched in zinc (92 mg/kg Zn). After the first day 8 rats in both groups 
received a supplementation of 10 mg/kg of zinc (as zinc acetate) in the diet. 
Blood (3ml) was taken under anaesthesia by heart puncture on days 0, 7, 
and 14. The serum was analyzed for zinc, magnesium and albumin 
concentration and for AP activity determined with reagents low or 
enriched in zinc.
2.2.5. Experiment 5: inflammatory stress, A P activity using buffers low and 
enriched in zinc
After an adaptation period of 7 days in which 64 rats, with a mean body 
weight of 200 g, were housed separately in stainless steel metabolic cages 
and raised on a standard IRI-OB diet, rats were divided into 2 groups of 
32 animals of equal mean body weight. To induce stress in one of these 
groups turpentine was injected intramuscularly in a dose of 0.25 ml into 
both hind legs to induce a long-standing inflammation. Before turpentine 
was injected, blood was collected from 4 rats in the inflammation group 
and 4 rats in the control group. Four hours, 1, 2, 3, 4, 7 and 14 days after 
the turpentine injection 2 ml blood were taken under ether anaesthesia by 
heart puncture from 4 rats in the inflammation group and from 4 rats in 
the control group, for determination of serum zinc, magnesium and
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albumin concentrations and determination of AP activity with reagents 
low or enriched in zinc. The control group was pair fed throughout the 
experiment. The total body retention of i.p. injected 65Zn served as a 
control to determine if zinc deficiency occurred. All the rats were injected 
i.p. with 74 kBq (2 /¿Ci) 65Zn 7 days before the turpentine injection. The 
total body activity at the time of the turpentine injection was taken as 
100%. Total body counting was performed after 4 h and on days 1, 2, 3, 
4, 7, and 14.
2.3. Materials
The diet (IRI-OB) was produced by Hope Farms (Woerden, The 
Netherlands) using components low in zinc (< 2  mg/kg Zn, [13]). In the 
zinc-sufficient diet zinc was added as sulphate to a final zinc concentration 
of 12 mg/kg. Sufficient quantities of other trace elements were also added. 
The Cu concentration in both versions of the diet was 9 mg/kg.
Stainless steel needles and plastic syringes (Monoject, Sherwood, USA) 
were used. All solutions were prepared with deionized distilled water 
(resistance >15  Mil), processed through a Millipore system (Bedford, 
MA).
Only polypropylene pipette tips, plastic tubes (15 ml polystyrene, 
Greiner, Solingen, Germany and 50 ml polypropylene, Falcon, Becton 
Dickinson and Company, Lincoln Park, NJ) and bottles (0.8 I, NUNC, 
Roskilde, Denmark) were used. All these materials were free of zinc 
contamination. All chemicals were of analytical grade (Merck, Darmstadt, 
Germany).
2.4. Determination o f zinc
All the determinations of zinc and AP activity were performed in a blind 
fashion. Zinc was determined by flame atomic absorption spec­
trophotometry (AAS; Perkin Elmer 5000; Norwalk, CT). The lower limit 
of detection was 0.28 ¿imol/1 and the response was linear till at least 15 
¡.iraol/l. Standard reference containing ZnCl2 (Tritisol, Merck, Darmstadt, 
Germany) was used in the concentrations expected to be found in the 
samples. No detectable zinc could be found in solutions and in deionized 
water used for the analytical experiments.
2.5. Determination o f AP activity
AP activity was determined at 30°C according to recommendations of 
the IFCC [15], except for the modification of the zinc concentration. A 
Multistat III centrifugal analyzer (Instrumentation Laboratory, IJssel- 
stein, The Netherlands) was used. 4-Nitrophenylphosphate and 2-amino- 
2-methyl-l-propanol (AMP) were provided by Instruchemie (Hilversum,
114 T.HJ. Naber et al I Clinica Chimica Acta 249 (1996) 109-127
The Netherlands). The AMP contained a relatively low concentration of 
zinc (1.6 /imol/1) and is used in clinical practice. Appropriate zinc supple­
mentation for the zinc-enriched modification of the AP activity determi­
nation resulted in a zinc concentration of 1.0 mmol/1 in the test assay 
mixture.
AMP buffers contain a chelator [16], which inhibits the activity of AP 
by removing zinc. By addition of zinc, this inactivation can be reversed. If 
high concentrations of the chelator are present in the buffer, more zinc 
should be added to compensate for the zinc-sequestering properties of the 
chelator. Thus the increase in activity of AP by zinc is in part due to the 
counteraction of the chelator and in part because zinc is a structural 
component in the enzyme. In the buffer used in the present experiments 
only a slight contamination was found using the method described by 
Derks et al. [17], implying that the low zinc concentration of the AMP 
buffer was valid. A buffer with a low zinc concentration was necessary to 
be able to detect small variations in serum zinc concentration by vari­
ations in the activity of the enzyme. If high concentrations of zinc were 
present in the buffer, small variations in the zinc concentration of the 
serum would not result in a variation in enzyme activity.
Final concentrations of the other components in the test mixture were: 
AMP 350 mmol/1, 4-nitrophenylphosphate 16 mmol/1, Na 140 mmol/1, 
Cl 160 mmol/1, phosphate 0.4 mmol/1, pH 10.3, magnesium as magnesium 
acetate 2.0 mmol/1.
2.6, Total body counting
The radio tracer 65Zn was supplied by Amersham International (Amer- 
sham, Buckinghamshire, UK, code ZAS 2, 3.7-37 GBq per mg Zn as 
chloride in 0.1 mol/1 HC1). Total body radioactivity of the rats was 
counted with a shadow shield counter consisting of 2 Tl-activated Nal 
crystals (4 x 6") connected to a Nuclear Data multi-channel analyzer 
N.D. 60 A (Nuclear Data; Schaumburg, IL).
2.7. Calculations
2.7.1. Biological half-life o f the. 65 Zn total body retention
The biological half-life (T|/2) of 65Zn was calculated from the total body 
retention in per cent measured as a function of time.
From the slope (A) of the linear part of the line, which is calculated by 
the least square method from the natural logarithm of the total body data, 
the biological half-life (T,/2) of the 65Zn was calculated using T1/2 =  In 2/X.
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2.7.2. Estimation o f the corrected serum zinc concentration in serum during 
stress
In case of inflammation the serum zinc concentration can be corrected 
for the decrease in serum albumin by increasing that part of the serum zinc 
concentration that is bound to albumin, to the same extent as the 
concentration of albumin in the inflammation group has to be increased 
to reach the level of the control group. That part of the total serum zinc, 
that is transported by albumin, should be increased by the factor Alb 
control/Alb inflammation. The corrected serum zinc concentration can be 
calculated by the equation:
Corr Zn tot (inflam) =  0.25 x Zn tot (control) +
Alb inflam
x ((Zn tot (inflam)) — (0.25 x Zn tot (control)))
where Zn tot (control) =  total serum zinc concentration of the control 
group; Corr Zn tot (inflam) =  corrected serum zinc concentration of the 
inflammation group; Alb control =  serum albumin of the control group; 
Alb inflam =  serum albumin of the inflammation group; Zn tot (in­
flam) =  total serum zinc concentration of the inflammation group.
The factor 0.25 represents the fraction of the serum zinc concentration 
that is mainly bound to the stable fraction of alpha macroglobulin, in rat 
a-1-macroglobulin [18] and in human a-2-macroglobulin. The concentra­
tion of this protein is not significantly changed by stress [18,19] and 
affinity of zinc to this protein is high [20], so that the number of zinc 
molecules transported by a-1-macroglobulin in the inflammation group 
will be equal to that of the control group. Using this equation we postulate 
that the binding of zinc to the binding proteins (the number of zinc 
molecules transported by one protein molecule), in the normal situation 
and in inflammation, will be similar, and that zinc bound to a-l-macro- 
globulin is not affected by inflammation. If a difference still remains 
between the corrected serum zinc concentration and the serum zinc 
concentration of the control group this will be due to other causes, e.g. 
redistribution of serum zinc into the liver.
2.7.3. Correction o f  AP activity 
A difference was seen between AP activity in the serum of rats 
determined with buffers low and enriched in zinc content. The results are 
provided without correction unless stated otherwise. To calculate the 
difference between both methods the assumption was made that the AP 
activities should be identical on day 0. The AP activity determined using
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a buffer low in zinc was corrected by using the following equation for each 
serum sample:
„ , ^ mean AP high Zn at day 0 . „  
Corr AP = --------------- ..........................- — x AP low Zn
mean AP low Zn at day 0
2.7.4. Statistics
The Wilcoxon rank sum test was used to compare the results in both 
groups of rats during a period of the experiment.
The Student r-test was performed on the data collected at one time- 
point; differences between 2 groups were considered significant if P <  0.05 
(two tails).
3. Results
3.1. Experiment 1
Normally in adult rats the total body retention of e5Zn is calculated as 
a percentage of injected dose immediately after administration. Because 2 
rats lost a significantly larger quantity of 65Zn (52 and 36%) compared to 
the other rats (5.55% S.D. 4.42%) during the first 24 h, the total body 
retention at day 1 is taken as 100%. Probably this greater loss can be 
explained by a partial injection of the 65Zn into the gut. When plotting 
the natural logarithm of the total body data of Experiment 1 vs. time, a 
linear relation was found from day 7 onwards. Zinc-deficient rats retained 
more 65Zn compared to control rats (T1/2 =  176 days vs. T )/2 =  51 days; 
Fig. la), confirming that these animals indeed had become zinc deficient.
Serum zinc and AP activity decreased gradually in the zinc-deficient rats 
(zinc: 11.7 vs. 29.3 /imol/1, P <  0.001 on day 21, Fig. lb; AP: 60 vs. 77 U/l, 
P < 0.01, Fig. lc). On day 28 the serum zinc concentration was 40% of 
that of control rats. No change was seen in the serum albumin concentra­
tion in the zinc-deficient rats. After 1 month zinc was added to the diet. 
Serum zinc and AP activity were normalized after 1 week.
3.2. Experiment 2
In growing rats on a zinc-deficient diet, serum zinc gradually decreased 
to 8.0 /¿mol/1 after 37 days (control group 24.7 /¿mol/l, P <  0.001; Fig. 2a). 
No significant difference was observed in the activity of AP between 
normal and zinc-deficient rats (Fig. 2b), but the activity decreased rapidly 
in both groups. In the zinc-deficient rats the lowest value was reached 
later.
(a)
(b)
(c)
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Alkaline phosphatase U/L
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Fig. 1. Zinc deficiency experiment in adult rats, (a) Total body retention of 65Zn in 
zinc-deficient adult rats (diet <2 mg/kg; •) and control rats (12 mg/kg; O). The total body 
retention of 65Zn 1 day after i.p. injection was taken as 100%. The error bars indicate 
standard deviations (***p = <0.001), (b) Serum zinc in zinc-deficient adult rats (diet <2 
mg/kg; •) and control rats (12 mg/kg; O; =  <0.01; ***P ~  <0.001). (c) Serum AP 
activity in zinc-deficient adult rats (diet <2 mg/kg; •) and control rats (12 mg/kg; O, 
**P= <0.01;***?= <0.001).
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Serum zinc ^Mol/L
DAYS
(b)
Alkaline phosphatase U/L
DAYS
Fig. 2. Zinc deficiency experiment in growing rats, (a) Serum zinc in zinc-deficient growing 
rats (diet <2 mg/kg; •) and control rats (12 mg/kg; O).  The error bars indicate standard 
deviations (***P =  < 0.001). (b) Serum AP activity in zinc-deficient and control growing 
rats (diet < 2 mg/kg; •) and control rats (12 mg/kg; O).
The activity was also determined using buffers low and enriched in zinc. 
At the first day (day 0) the difference between the AP activity using buffers 
with a low and an enriched zinc content was, in the zinc-deficient group, 
21 U/l, and in the control group, 24 U/l. Serum AP activity using both 
methods should by definition be identical at day 0. Using the equation 
mentioned in Section 2.7, the AP activity using a buffer low in zinc was 
corrected.
The AP activity in zinc-deficient rats, determined using a buffer low in 
zinc and a buffer enriched in zinc is shown (Fig. 3a). The reagents low in
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(a)
(b)
(C) Difference in activity U/L
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Fig. 3. Zinc deficiency experiment in growing rats, (a) Serum AP activity in zinc-deficient 
rats, using buffers low (•) and enriched (O) in zinc. The error bars indicate standard 
deviations (*P =  <0.05). (b) Serum AP activity in control rats, using buffers low (•) and 
enriched (O) in zinc, (c) Difference in AP activity by using buffers low and enriched in zinc, 
between zinc-deficient rats (•) and control rats (O) (*/> =  <0.05, **p  = <0.01; 
* * * p  =  < 0 .0 0 1 ) .
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zinc result in a lower AP activity during the study. In Fig. 3b the same is 
shown for the control rats. Comparing Figs. 3a and b the difference 
between both methods is greater in zinc-deficient rats than control rats. In 
Fig. 3c this difference is shown. This difference was highly significant at 
individual points after inducing zinc deficiency and for the total period
using the Wilcoxon rank sum test (P <  0.001).
3.3. Experiment 3
Because of the results in Experiment 2 the difference in AP activity using 
buffers low and enriched in zinc was also studied in adult rats. The results 
of this experiment confirmed the results in Experiment 1, especially the 
serum zinc and AP activity.
After correction for the difference in AP activity with the reagents low 
and enriched in zinc at day 0, a significant difference was observed in AP 
activity for the total period using the Wilcoxon rank sum test (P =  0.01) 
and for individual sample times on day 20 (Fig. 4).
3.4. Experiment 4
In this experiment the results of zinc supplementation in normal 
quantities was studied in rats raised on a diet with sufficient zinc and on 
a diet rich in zinc. N o change in time or difference between the group 
supplemented by extra zinc and the control group was observed in serum 
zinc concentration and in AP activity.
Difference in activity U/L.
Fig. 4. Zinc deficiency experiment in adult rats. Difference in AP activity by using buffers 
low and enriched in zinc, between zinc-deficient adult rats (•) and control rats (O). A 
significant difference was observed using a Wilcoxon rank sum test, and on day 20 using 
a Student i-test. The error bars indicate standard deviations (**ƒ> = <0.01).
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3.5. Experiment 5
The total body retention of 65Zn (Fig. 5a) showed no difference between 
the groups, indicating that zinc deficiency did not occur during inflamma­
tory stress (inflammation group T!/2 =  34 days, control group T 1/2 =  31.5 
days). None of the rats showed symptoms of zinc deficiency, such as loss 
of hair. The serum albumin concentration decreased during the first day. 
Thereafter a constant difference persisted (23.8 vs. 31.3 g/1, P  <  0.0005; Fig. 
5b). Using a Wilcoxon rank sum test a highly significant difference was 
calculated if all the data of both groups were compared (P <  0.0001). 
Simultaneously during the first day a considerable decrease in serum zinc 
concentration was seen in the rats with stress (day 1: inflammation group 
10.3 ¿jmol/1 and control group 23.0 ¿¿mol/1, P  =  0.002; Fig. 5c). After the 
first few days a smaller difference persisted. A Wilcoxon rank sum test was 
performed for comparison of the independent results of both groups of 
rats on all the data collected during the experiment. A highly significant 
difference was calculated (P <  0.0001). When the serum zinc concentration 
of the rats with an inflammation was corrected for the decrease in serum 
albumin using the equation described in Materials and methods, the 
differences between the groups largely disappeared, especially after the 
third day (Fig. 5c). A decrease in AP activity was only seen on the first 2 
days (71 vs. 115 U/l, P <  0.05; Fig. 6a). Using the same method described 
in Section 2.7 and applied in Experiments 2 and 3, a significant difference 
was also observed in AP activity determined using buffers low and 
enriched in zinc. This difference largely disappeared after the fourth day 
(Fig. 6b). During these experiments no changes in serum magnesium 
concentrations were demonstrated.
4. Discussion
The total body retention of 65Zn as a function of time served as an 
indication of zinc status. In Experiment 1, in which adult rats were made 
zinc deficient, the 65Zn total body retention confirmed that the animals 
had become zinc deficient. To detect eventual changes in zinc status during 
the first hours and days of the inflammatory stress experiment (Experi­
ment 5), we preferred a linear decrease in the total body retention, so 65Zn 
was injected 7 days before the turpentine injection. During the inflamma­
tory stress experiment no difference in 65Zn retention was observed 
between the rats with inflammatory stress and the control rats, indicating
that no zinc deficiency occurred.
After introduction of a zinc-deficient diet the serum zinc concentration 
fell in adult, and more impressively in growing, rats. Normalization of the 
diet resulted in an increase in serum zinc concentration. Supplementation
122 T.H.J. Naber et al / Clinica Chimica Acta 249 (1996) 109-127
Tota! body retention 
%
DAYS
DAYS
(c) Serum Zinc (jmol/L
DAYS
Fig. 5. Inflammatory stress experiment, (a) Total body retention of G5Zn in rats with an 
inflammation (•) and control rats (O) during the experiment, (b) Serum albumin 
concentrations in rats with an inflammation (•) and control rats (O) during the experiment
< 0 .001). (c) Serum zinc concentrations in rats with an inflammation (•) and control 
rats (O) and serum zinc concentrations corrected for the decrease in serum albumin (A) 
during the experiment. The error bars indicate standard deviations (*P = < 0.05; 
**P <0.01; ***P < 0.001, for serum zinc in rats with an inflammation compared with 
control rats, and ++P<0.05; + + +P<0.01 for corrected serum zinc in rats with an 
inflammation compared with control rats).
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(a) Alkaline phospatase U/L
DAYS
(b) Difference in activity U/L
DAYS
Fig. 6. Inflammatory stress experiment, (a) Serum AP activity in rats with an inflammation 
(•) and control rats (O) during the experiment (**P <  0.01). (b) Difference in AP activity 
by using buffers low and enriched in zinc, between rats with inflammatory stress (•) and 
control rats (O)- The error bars indicate standard deviations (*P = <0.05; **P =  <0.01; 
***p = < 0.001).
with the same quantity of zinc in the diet of control rats did not influence 
the serum zinc concentrations.
After induction of inflammatory stress the serum zinc concentration 
decreased rapidly. This decrease continued during the first 3 days, after 
which a smaller difference persisted. The serum albumin concentration 
decreased within 1 day to a level which remained stable throughout the
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experiment. After correction of the serum zinc concentration for the 
decrease in serum albumin, no difference in serum zinc concentration was 
observed after the second day. This indicates that after the initial phase of 
inflammatory stress the decrease in serum zinc is mainly due to a decrease 
in serum albumin. Probably the initial rapid decrease in serum zinc is 
caused by an increase in zinc uptake by the liver, an observation that has 
been demonstrated by Solomons et al. [21].
The determination of activity of zinc-dependent enzymes has been used 
as a method to determine zinc status, e.g. serum AP activity [22]. The AP 
activity is limited by the influence of liver function and bone turnover, 
factors that influence the concentration of AP enzyme. The advantage of 
using AP activity as a method to determine zinc status is that the 
determination of AP activity is possible in every clinical laboratory. Serum 
AP activity is the result of 2 factors: the protein concentration of the 
enzyme in the serum and the activity of the enzymatic molecules. The 
former factor is influenced by release of the enzyme by AP-containing 
tissues, mainly liver and bone. The latter factor is influenced by the 
number of zinc and magnesium atoms in the AP enzyme molecule 
[10-12], During the experiments no changes in magnesium concentration 
were observed. The zinc deficiency experiments in adult rats confirmed 
that serum AP activity is decreased in zinc deficiency. Sandstead et al. [23] 
demonstrated an increase in serum zinc concentration and AP activity 
during zinc deprivation in marginally zinc-deficient men. This was not 
confirmed in rats in the present experiments. The increase in AP activity 
after zinc supplementation may be an indication of a preceding zinc 
deficiency (Experiment 1). Our experiments confirmed studies in animals 
[2 4 -2 6 ] and in patients [27,28]. No increase was demonstrated in case of 
zinc sufficiency (Experiment 4). Kasarkis and Shuna [25] proposed the AP 
ratio (the magnitude of the increase in AP activity after zinc supplement­
ation) as an indicator of zinc status. Some criticism can be addressed to 
this method. The results of Experiment 4 demonstrated that this method, 
the AP ratio, cannot be used to differentiate between rats receiving food 
with a marginal but sufficient quantity of zinc and rats receiving a diet rich 
in zinc. In growing rats (Experiment 2), no difference was observed 
between normal and zinc-deficient rats. In a study in infants the same 
problem was observed; no correlation was demonstrated between serum 
zinc and AP activity [29]. During growth the AP activity declines because 
of a decrease in concentration of the enzyme. In zinc deficiency growth is 
retarded. Perhaps the concentration of the AP enzyme in the serum 
remains high in the zinc-deficient rats, which counteracts the decrease in 
activity of the enzyme due to a decrease in zinc concentration. In the 
zinc-deficient rats the lowest AP activity value was reached later.
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In the inflammatory stress experiment AP activity was decreased during 
the initial phase of inflammation, showing that AP activity is influenced 
by inflammatory stress. This is not known from clinical practice [30], 
although in physiological stress experiments published in veterinary jour­
nals a decrease in AP activity has been observed [31] (without explana­
tion). After the initial phase no difference in AP activity was observed in 
the present experiment, although serum zinc was still decreased. The 
normalisation of the serum zinc concentration after correction for the 
decrease in serum albumin indicates that, after the second day, the 
decrease in serum zinc was mainly due to a decrease in serum albumin. 
Probably AP activity is influenced by the shift of serum zinc into the liver 
during the first days after inducing inflammatory stress, but not by an 
apparent decrease of serum zinc due to a decrease of serum albumin in 
long-lasting inflammation. AP activity probably reflects the serum concen­
tration of free zinc.
We postulated that in case of zinc deficiency the difference of AP 
activity, determined in a buffer low and a buffer enriched in zinc, would 
be greater than in zinc sufficiency. This method would largely bypass the 
influence of the concentration of the enzyme on the assessment of AP 
activity and the influence of other minerals such as magnesium, and offers 
the opportunity of having a instantaneous monitor of zinc status. In our 
experiments the concentrations in the buffer were chosen within the range 
of zinc concentrations used in laboratory practice because it is well known 
that very low (see Materials and methods) and high concentrations in the 
AMP buffer (several times higher than the concentrations used in clinical 
practice) added in vitro, will decrease serum AP activity [11,26,32]. The 
hypothesis was confirmed in Experiment 2 in zinc-deficient growing rats, 
in Experiment 5 in rats with inflammatory stress, and in Experiment 3 in 
zinc-deficient adult rats. At individual sampling times this was highly 
significant in growing rats and rats with inflammatory stress. In zinc- 
deficient adult rats this difference was smaller due to rather large standard 
deviations caused by physiological differences and the limited number of 
animals. The method could be improved by increasing the difference of the 
AP activity. Essential for this method is the use of an AMP buffer with a 
low concentration of chelator and consequently low zinc concentration. 
To our knowledge only one study has suggested that manipulation of the 
method of determination of AP activity could be used for the diagnosis of 
zinc deficiency [33]. In this study a method was described in which 
inactivated AP was reactivated by serum. Also in this study a greater 
difference was observed in zinc deficiency.
We may conclude that the experiments demonstrate that, in case of a 
low serum zinc concentration, the difference in AP activity probably can
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differentiate between a true zinc deficiency and an apparent zinc deficiency 
due to a decrease in serum albumin, even if AP enzyme levels are 
changing. This method should be confirmed in humans.
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